BioRestorative Therapies Inc (NASDAQ:BRTX) traded at $2.29 at close of the session on current trade day and made a downward move of -6.91% on its previous day’s price.
Looking at the stock we see that its previous close was $2.46 and the beta (5Y monthly) reads 61.979 with the day’s price range being $2.29 – $2.42. In terms of its 52-week price range, BRTX has a high of $2.55 and a low of $1.03. The company’s stock has gained about 27.22% over that past 30 days.
BioRestorative Therapies Inc has a market cap of $15.85 million and is expected to release its quarterly earnings report in March.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 475k, with a low of 450k and a high of 500k. The median projection represents growth squeezing down to 2,361.14% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 833k, or 471.33% up from figures reported last year.
On the other hand, looking at the outlook for the BRTX stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 100% Buy.
Looking further, we note the current price level is -1.64% off its SMA20 and 22.83% from its 50-day simple moving average. The RSI (14) is pointing at 54.73 while the volatility over the past week is 7.79% and jumps to 9.00% over the past one month. The beta value is 63.48, while the average true range (ATR) is currently pointing at 0.18.
Coming back to BioRestorative Therapies Inc (NASDAQ:BRTX), we note that the average 3-month trading volume was 74.21K, while that of the preceding 10-day period stands at 72570.0. Current shares outstanding are 6.92 million.
The insiders hold 26.61% of the company’s shares while institutions hold 13.94%. The data shows that short shares as of 2025-01-31, stood at 0.24 million at a short ratio of 3.29. This represents a 417.00 short interest in shares outstanding on 2025-01-31. Shares short rose in January from the previous month at 0.11 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 60.14% up in year-to-date price movement.
